244 related articles for article (PubMed ID: 14734652)
1. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.
De la Vieja A; Ginter CS; Carrasco N
Mol Endocrinol; 2005 Nov; 19(11):2847-58. PubMed ID: 15976004
[TBL] [Abstract][Full Text] [Related]
3. Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.
Dohán O; Gavrielides MV; Ginter C; Amzel LM; Carrasco N
Mol Endocrinol; 2002 Aug; 16(8):1893-902. PubMed ID: 12145342
[TBL] [Abstract][Full Text] [Related]
4. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
5. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
6. Implications of the molecular characterization of the sodium-iodide symporter (NIS).
Schmutzler C; Köhrle J
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 3():S1-10. PubMed ID: 9865544
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.
Reed-Tsur MD; De la Vieja A; Ginter CS; Carrasco N
Endocrinology; 2008 Jun; 149(6):3077-84. PubMed ID: 18339708
[TBL] [Abstract][Full Text] [Related]
8. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the sodium/iodide symporter (NIS) gene as a cause for iodide transport defects and congenital hypothyroidism.
Pohlenz J; Refetoff S
Biochimie; 1999 May; 81(5):469-76. PubMed ID: 10403177
[TBL] [Abstract][Full Text] [Related]
10. Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients.
Kosugi S; Inoue S; Matsuda A; Jhiang SM
J Clin Endocrinol Metab; 1998 Sep; 83(9):3373-6. PubMed ID: 9745458
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
12. Perchlorate transport and inhibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L.
Cianchetta S; di Bernardo J; Romeo G; Rhoden KJ
Toxicol Appl Pharmacol; 2010 Mar; 243(3):372-80. PubMed ID: 20005887
[TBL] [Abstract][Full Text] [Related]
13. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters.
Pohlenz J; Duprez L; Weiss RE; Vassart G; Refetoff S; Costagliola S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2366-9. PubMed ID: 10902780
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.
Pohlenz J; Medeiros-Neto G; Gross JL; Silveiro SP; Knobel M; Refetoff S
Biochem Biophys Res Commun; 1997 Nov; 240(2):488-91. PubMed ID: 9388506
[TBL] [Abstract][Full Text] [Related]
15. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD.
Szinnai G; Kosugi S; Derrien C; Lucidarme N; David V; Czernichow P; Polak M
J Clin Endocrinol Metab; 2006 Apr; 91(4):1199-204. PubMed ID: 16418213
[TBL] [Abstract][Full Text] [Related]
16. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization.
Dayem M; Basquin C; Navarro V; Carrier P; Marsault R; Chang P; Huc S; Darrouzet E; Lindenthal S; Pourcher T
J Endocrinol; 2008 Apr; 197(1):95-109. PubMed ID: 18372236
[TBL] [Abstract][Full Text] [Related]
17. A novel V59E missense mutation in the sodium iodide symporter gene in a family with iodide transport defect.
Fujiwara H; Tatsumi K; Tanaka S; Kimura M; Nose O; Amino N
Thyroid; 2000 Jun; 10(6):471-4. PubMed ID: 10907989
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Kogai T; Taki K; Brent GA
Endocr Relat Cancer; 2006 Sep; 13(3):797-826. PubMed ID: 16954431
[TBL] [Abstract][Full Text] [Related]
19. Enhanced iodide sequestration by 3-biphenyl-5,6-dihydroimidazo[2,1-b]thiazole in sodium/iodide symporter (NIS)-expressing cells.
Lecat-Guillet N; Ambroise Y
ChemMedChem; 2008 Aug; 3(8):1211-6. PubMed ID: 18470848
[TBL] [Abstract][Full Text] [Related]
20. Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).
Li W; Nicola JP; Amzel LM; Carrasco N
FASEB J; 2013 Aug; 27(8):3229-38. PubMed ID: 23650190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]